Press release
Cancer Biomarkers Market Survey Report 2020 Along with Statistics, Forecasts till 2026
Top Companies in the Global Cancer Biomarkers Market
Abbott Laboratories (NYSE: ABT), Thermo Fisher Scientific Inc. (NYSE:TMO), F. Hoffmann-La Roche Ltd, Illumina,Inc., Agilent Technologies, Qiagen NV, Merck & Co., Hologic,Inc., Novartis AG, BioMerieux SA, Genomic Health, Inc.(Nasdaq: GHDX), Affymetrix, Roche Diagnostics Ltd., among others.
The global Cancer Biomarkers market is valued at US$ 11710 million in 2020 is expected to reach US$ 18790 million by the end of 2026, growing at a CAGR of 6.9% during 2021-2026.
Market Overview:
Biomarkers are chemical, physical or biological parameters, which can be used to indicate disease states. Oncology biomarkers offer high speed, non-invasive cancer diagnosis, and are believed to enhance cancer detection and screening. Major driving factors for the market are streamlined drug delivery process, noninvasive technology, and increased rates of survival.
Get Free Sample PDF Copy of Latest Research on Cancer Biomarkers Market 2020 Before the purchase
https://www.marketinsightsreports.com/reports/04161995388/global-cancer-biomarkers-market-research-report-2020/inquiry?Mode=46&Source=Openpr
Market Insights
- Globally, cancer is one of the leading causes of death. In 2015, it accounted for 8.8 million deaths, causing nearly one in every six deaths.
- The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period.
- The World Health Organization (WHO) estimates the rate of cancer number to increase to 70% over the next two decades.
- Additionally, the increased burden of several lifestyle disorders is also expected to drive the market, as biomarkers play a vital role in risk assessment, early diagnosis, and effective monitoring of treatment.
- According to the WHO, almost 70% of deaths from cancer occur in low- and middle-income countries, and only one in five low- and middle-income countries has the necessary data to drive its cancer policy.
Key Market Trends
North America Dominates the Market and is Expected to do the Same Over the Forecast Period
The United States witnessed a considerable rise in the number of cancer patients. Prostate and breast cancers are the most prevalent forms of cancer in the region. According to the estimates of the American Cancer Society, in the United States, around 220,800 new cases of prostate cancer were diagnosed and about 27,540 deaths occurred due to this cancer, in 2015. Additionally, it is estimated that, currently, there are nearly three million American men suffering from prostate cancer. In 2015, an estimated 246,660 new cases of invasive breast cancer and 60,290 additional cases of in-situ breast cancer were diagnosed among women in the United States. The ease in the US government regulations and availability of funds from various organizations, like the National Institute of Health, have provided the potential for researchers to invest more in the use of biomarkers in drug discovery, drug development, detection of specific tumors, monitoring biological response to cancer therapy, and genetic studies for the identification of predisposed candidates of cancer.
Key Developments in the Market
January 2018: Roche and GE entered into a partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment. This partnership will apply advanced analytics to in-vivo data from GEs medical imaging and monitoring equipment with in-vitro data from Roches biomarker, tissue pathology, genomics, and sequencing portfolio.
January 2018: New biomarkers found for colorectal cancer (MYO5B).
November 2017: Researchers found a new biomarker for breast cancer (GIRK1).
October 2017: ABBOTT acquired ALERE.
September 2017: Roche announced its progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress.
Trending News
Genomic Health, Inc.(Nasdaq: GHDX)
Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue
REDWOOD CITY, Calif.,Feb. 3, 2011 / --Genomic Health, Inc.(Nasdaq: GHDX) today announced that its scientists successfully surveyed expression of the whole human transcriptome using next-generation DNA sequencing technology developed by Illumina, Inc., to test hypotheses for biomarker discovery in archived tumor and normal breast tissue samples. The study identified hundreds of coding and non-coding transcripts that are differentially expressed in tumor versus normal, non-cancerous breast tissue, including a subset of genes statistically associated with the recurrence of breast cancer.
(Source=investor.genomichealth.com)
The Cancer Biomarkers market can be divided based on product types and its sub-type, major applications and Third Party usage area, and important regions.
This report segments the global Cancer Biomarkers Market on the basis of Types are
Protein Biomarkers, Genetic Biomarkers, Others
On The basis Of Application, the Global Cancer Biomarkers Market is Segmented into
Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer
(Exclusive Offer: Flat 30% discount on this report)
Inquire for Discount
https://www.marketinsightsreports.com/reports/04161995388/global-cancer-biomarkers-market-research-report-2020/discount?Mode=46&Source=Openpr
Regions Are covered By Cancer Biomarkers Market Report 2020 To 2026.
North America, Europe, China, Japan, Southeast Asia, India.
North America (USA, Canada and Mexico).
Europe (Germany, France, UK, Russia and Italy).
Asia-Pacific (China, Japan, Korea, India and Southeast Asia).
Significant Features that are under Offering and Key Highlights of the Reports:
-Detailed overview of Cancer Biomarkers Market
-Changing Cancer Biomarkers market dynamics of the industry
-In-depth market segmentation by Type, Application etc.
-Historical, current and projected Cancer Biomarkers market size in terms of volume and value
Recent industry trends and developments
-Competitive landscape of Cancer Biomarkers Market
-Strategies of key players and product offerings
-Potential and niche segments/regions exhibiting promising growth.
Frequently Asked Questions about Cancer Biomarkers market:
- What are the recent developments and government policies?
- Why might we forecast a downturn in a particular economy next year?
- Why do we say a currency is set to appreciate?
- What countries and sectors offer the highest potential?
- Where are the greatest dangers?
The report has 150 tables and figures browse the report description and TOC
https://www.marketinsightsreports.com/reports/04161995388/global-cancer-biomarkers-market-research-report-2020?Mode=46&Source=Openpr
We Also Offer Customization on report based on specific client Requirement
Free country Level analysis for any 5 countries of your choice.
Free Competitive analysis of any 5 key market players.
Free 40 analyst hours to cover any other data point.
All the reports that we list have been tracking the impact of COVID-19 the market. Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.
Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States
Contact US :
Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com
ABOUT US
Market Insights Reports is an online market research reports library of 500,000 in-depth studies of over 5000 micro markets. Market Insights Reports offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Survey Report 2020 Along with Statistics, Forecasts till 2026 here
News-ID: 2054523 • Views: …
More Releases from Market Insights Reports
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world.
Some of the key players…
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
